Shree Ganesh Remedies Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 219.95 million compared to INR 211.28 million a year ago. Revenue was INR 233.94 million compared to INR 220.07 million a year ago. Net income was INR 43.5 million compared to INR 42.03 million a year ago. Basic earnings per share from continuing operations was INR 3.62 compared to INR 3.5 a year ago. Diluted earnings per share from continuing operations was INR 3.62 compared to INR 3.5 a year ago.
For the nine months, sales was INR 608.93 million compared to INR 507.3 million a year ago. Revenue was INR 636.72 million compared to INR 531.57 million a year ago. Net income was INR 111.53 million compared to INR 95.59 million a year ago. Basic earnings per share from continuing operations was INR 9.29 compared to INR 7.96 a year ago. Diluted earnings per share from continuing operations was INR 9.29 compared to INR 7.96 a year ago.